Trial Profile
Clinical Trials Insight: 700039829
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 15 Dec 2008
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide; Etoposide
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi Genzyme
- 15 Dec 2008 New trial record.
- 09 Dec 2008 Phase I and preliminary phase II results presented at the American Society of Hematology.
- 09 Dec 2008 To date, 12 patients have been enrolled in the phase II portion.